Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis

Clicks: 179
ID: 269439
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #20 of 33 articles by views in Turkish journal of medical sciences

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Malignancy was associated with up to 2.3-fold higher risk of severe/critical COVID-19 and may serve as a clinical predictor for adverse outcomes.
Reference Key
ge2021turkishmalignancy Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Liu GE;Cai W;Liu H;Jiang HH;Yi Bi Y;Wang H;;
Journal Turkish journal of medical sciences
Year 2021
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/34022777
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:34022777 doi:10.3906/sag-2101-192 G E Liu Wei Cai Hong Wang

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.